skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
05/14/2019
Application #:
14911533
Filing Dt:
02/11/2016
Publication #:
Pub Dt:
06/30/2016
Inventors:
Nadine Nagy, Hedwich F. Kuipers, Paul L. Bollyky, Thomas Wight
Title:
4-METHYLUMBELLIFERONE TREATMENT FOR IMMUNE MODULATION
Assignment: 1
Reel/Frame:
038203/0111Recorded: 04/06/2016Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/14/2016
Exec Dt:
03/24/2016
Assignee:
1705 EL CAMINO REAL
PALO ALTO, CALIFORNIA 94306
Correspondent:
MELISSA A. NOWAK, ESQ.
CHRISTENSEN O'CONNOR JOHNSON KINDNESS
1201 THIRD AVENUE, SUITE 3600
SEATTLE, WA 98101-3029
Assignment: 2
Reel/Frame:
038363/0799Recorded: 04/06/2016Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
03/10/2016
Exec Dt:
04/01/2016
Assignee:
1201 NINTH AVENUE
SEATTLE, WASHINGTON 98101
Correspondent:
MELISSA A. NOWAK, ESQ.
CHRISTENSEN O'CONNOR JOHNSON KINDNESS
1201 THIRD AVENUE, SUITE 3600
SEATTLE, WA 98101-3029
Assignment: 3
Reel/Frame:
039298/0482Recorded: 07/11/2016Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/23/2016
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 05/12/2024 04:47 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT